us en false false Default
Skip directly to Accessibility Notice
PPH VanEck Pharmaceutical ETF Please read important disclosure Close important disclosure false

PPH
VanEck Pharmaceutical ETF

PPH
VanEck Pharmaceutical ETF

  • NAV
    $104.17

    as of April 02, 2026
  • YTD RETURNS
    1.02%

    as of April 02, 2026
  • Total Net Assets
    $1.05B

    as of April 02, 2026
  • Total Expense Ratio
    0.36%
  • Inception Date
    12/20/2011

About PPH

VanEck Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.

Buy Now
Let's Connect
Subscribe

Overview

Why PPH

  • Highly Liquid Companies: Tracks the largest most liquid pharmaceutical companies
  • Industry Leaders: Favors established industry leaders with meaningful scale
  • Global Scope: Provides exposure to U.S. and international equities for global industry representation  

Performance

Performance History:

Average Annual Total Returns* (%)

View All ETFs View All Indices
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 4.61 9.25 8.32 21.70 16.20 12.72 8.95 10.50
PPH (Market Price) 4.58 9.29 8.27 21.72 16.20 12.68 8.95 10.57
MVPPHTR (Index) 4.59 9.23 8.27 21.38 15.75 12.34 8.72 10.31
Performance Differential (NAV - Index) 0.02 0.02 0.05 0.32 0.45 0.38 0.23 0.19
  1 MO 3 MO YTD 1 YR 3 YR 5 YR 10 YR LIFE
12/20/11
PPH (NAV) 0.86 14.97 21.92 21.92 12.11 11.34 6.74 10.00
PPH (Share Price) 0.95 15.00 22.03 22.03 12.14 11.34 6.73 10.08
MVPPHTR (Index) 0.89 15.01 21.58 21.58 11.64 10.88 6.49 9.81
Performance Differential (NAV - Index) -0.03 -0.04 0.34 0.34 0.47 0.46 0.25 0.19

*Returns less than one year are not annualized.

The performance data quoted represents past performance. Past performance is not a guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Performance may be lower or higher than performance data quoted. Please call 800.826.2333 or visit vaneck.com for performance current to the most recent month ended.

Prices as of 04/02/2026

NAV/
Market
Price 		Volume
30-Day Avg./
Last Trading Day 		Daily Change
NAV/
Last Price 		YTD Change NAV/
Last Price 		Premium/
Discount 		30-Day
Median
Bid Ask
Spread 		NAV
Chart
PPH $104.17
$104.16 		430,728
173,057 		$-0.47 / -0.44%
$-0.47 / -0.45% 		+1.02%
+0.96% 		$-0.01
-0.01% 		0.04%

Fees

Holdings

Daily Holdings (%) as of 04/02/2026

Download XLS Get holdings
Total Holdings: 26
Ticker
 Holding Name % of Net
Assets
Identifier (FIGI)
Shares
 Asset Class Market Value
(US$) 		Notional Value
LLY
 Eli Lilly & Co 18.92
BBG000BNBDC2
211,495
 Stock 197,870,492 --
NVS
 Novartis Ag 10.85
BBG000LYF3S8
736,533
 Stock 113,448,178 --
MRK
 Merck & Co Inc 9.72
BBG000BPD168
841,266
 Stock 101,683,821 --
PFE
 Pfizer Inc 5.24
BBG000BR2B91
1,936,407
 Stock 54,839,046 --
NVO
 Novo Nordisk A/S 4.81
BBG000BQBKR3
1,361,409
 Stock 50,344,905 --
GSK
 Gsk Plc 4.70
BBG000BLB481
867,002
 Stock 49,150,343 --
SNY
 Sanofi Sa/France 4.68
BBG000BBD5N1
1,020,826
 Stock 48,887,357 --
BMY
 Bristol-Myers Squibb Co 4.54
BBG000DQLV23
797,213
 Stock 47,513,895 --
AZN
 Astrazeneca Plc 4.52
BBG000D3MHB4
232,053
 Stock 47,220,465 --
MCK
 Mckesson Corp 4.33
BBG000DYGNW7
51,176
 Stock 45,253,913 --
JNJ
 Johnson & Johnson 4.31
BBG000BMHYD1
185,521
 Stock 45,089,024 --
ABBV
 Abbvie Inc 3.94
BBG0025Y4RY4
197,029
 Stock 41,147,536 --
COR
 Cencora Inc 3.84
BBG000MDCQC2
123,725
 Stock 40,185,880 --
ZTS
 Zoetis Inc 3.45
BBG0039320N9
305,778
 Stock 36,063,457 --
HLN
 Haleon Plc 3.18
BBG018GZNCH6
3,344,498
 Stock 33,210,865 --
TAK
 Takeda Pharmaceutical Co Ltd 3.17
BBG000LF8708
1,767,826
 Stock 33,129,059 --
TEVA
 Teva Pharmaceutical Industries Ltd 2.81
BBG000C0CD58
977,371
 Stock 29,399,320 --
VTRS
 Viatris Inc 0.89
BBG00Y4RQNH4
691,620
 Stock 9,295,373 --
JAZZ
 Jazz Pharmaceuticals Plc 0.79
BBG000G9CGL0
44,068
 Stock 8,238,513 --
AXSM
 Axsome Therapeutics Inc 0.51
BBG00B6G7GL7
31,631
 Stock 5,329,982 --
ELAN
 Elanco Animal Health Inc 0.34
BBG00LJYS1P8
153,699
 Stock 3,547,373 --
CORT
 Corcept Therapeutics Inc 0.23
BBG000BKJG33
57,326
 Stock 2,435,782 --
OGN
 Organon & Co 0.10
BBG00ZQRGW24
170,186
 Stock 1,082,383 --
BHC
 Bausch Health Cos Inc 0.10
BBG000DLFM21
199,846
 Stock 1,069,176 --
PRGO
 Perrigo Co Plc 0.07
BBG000CNFQW6
68,106
 Stock 738,950 --
-USD CASH-
 0.40
--
4,151,374
 Cash Bal 4,151,374 --
--
Other/Cash -0.45
--
0
 Cash -4,665,874 --
← Scroll for more information →
These are not recommendations to buy or to sell any security. Securities and holdings may vary.

Portfolio

Sector Weightings (%) as at 02/28/2026

  • Sector

    % of Net Assets

  • Health Care

    99.96

  • Other/Cash

    0.04

Country Weightings (%) as at 02/28/2026

  • Country

    % of Net Assets

  • United States

    62.18

  • United Kingdom

    12.48

  • Switzerland

    11.37

  • Denmark

    4.40

  • France

    4.04

  • Japan

    2.88

  • Israel

    2.62

  • Other/Cash

    0.04

Distributions

Yields  as of  04/02/2026

Distribution Frequency

Quarterly

30-Day SEC Yield

1.98%

Distribution Yield

3.24%

12 Month Yield

2.07%

Yield information reflects temporary waivers of expenses and/or fees. Yields would have been reduced had these fees/expenses been included. In the absence of temporary expense waivers or reimbursements, the 30-Day SEC Yield for VanEck Pharmaceutical ETF would have been 1.98% on 04/02/26. Distributions may vary from time to time.

Team

Literature

PPH